… and lung cancer over the course of cancer care. Our findings highlight the use of multiple
supportive care medications … cancer patients receiving chemotherapy. Physician assessment of …

… Lung cancer is the leading cause of cancer deaths in the US for both men and women, with
… Non-small cell lung cancer (NSCLC) comprises approximately 85% of lung cancer cases …

… or PIMs among older lung cancer patients. To date, there have been no systematic reviews
or meta-analyses about the use of PIMs and polypharmacy in older lung cancer patients. To …

… use of several analytic strategies, we found no indications that participation in a Danish lung
cancer … in prescription of antidepressants and anxiolytic medications. This indicates that CT …

… lung cancer are using many inappropriate medications in view of their terminal prognosis.
The futile use of medication … in the literature for patients with cancer, advanced dementia and …

… with lung cancer, knowing that this population has a high multimorbidity and a poor prognosis
[34]. Since the majority of the patients with lung cancer … assess which medication can be …

… use and a value of 0 denoted non-regular use. We defined regular medication use in a period
as a medication … In our study, patients with lung cancer showed a trend in medication use …

… In the present study, the impact of concomitant medication use on the efficacy and safety of
… and our study revealed that use of other concomitant medications had no significant effect on …

… causal effect of sleep disorders on lung cancer incidence is still lacking, many lung cancer
patients were also diagnosed with sleep disorders or pain in our study. Use of estazolam, a …

… The medication adherence of patients with lung cancer in this study was better than that of
patients with other diseases reported in other studies. Previous studies have shown that the …